BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1028634)

  • 21. The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans.
    Grottoli S; Giordano R; Maccagno B; Pellegrino M; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4616-20. PubMed ID: 12364444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
    Westerhof I; Van den Brom WE; Mol JA; Lumeij JT; Rijnberk A
    Avian Dis; 1994; 38(3):435-45. PubMed ID: 7832695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
    Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
    Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cloprednol therapy in steroid-dependent asthma.
    Shapiro GG; Tattoni DS; Kelley VC; Pierson WE; Dorsett CS; Bierman CW
    Pediatrics; 1979 May; 63(5):747-53. PubMed ID: 440895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single daily dose corticosteroid treatment.
    Myles AB; Schiller LF; Glass D; Daly JR
    Ann Rheum Dis; 1976 Feb; 35(1):73-76. PubMed ID: 1275584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study.
    Pasquali R; Ambrosi B; Armanini D; Cavagnini F; Uberti ED; Del Rio G; de Pergola G; Maccario M; Mantero F; Marugo M; Rotella CM; Vettor R;
    J Clin Endocrinol Metab; 2002 Jan; 87(1):166-75. PubMed ID: 11788642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cortisol levels in normal subjects after inhaled corticosteroids.
    Sparkes CG
    Postgrad Med J; 1974 Sep; 50 suppl 4():9-11. PubMed ID: 4467157
    [No Abstract]   [Full Text] [Related]  

  • 28. Responsiveness of the glucocorticoid-suppressed pituitary-adrenocortical system of pigeons (Columba livia domestica) to stimulation with arginine vasopressin.
    Westerhof I; Van den Brom WE; Mol JA
    Avian Dis; 1996; 40(2):312-20. PubMed ID: 8790880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of the hypothalamus-pituitary-adrenal system by intra-articular triamcinolone diacetate.
    Wellington JE; van Kan BL; Jaitly KD
    J Endocrinol; 1970 Dec; 48(4):lxxx+. PubMed ID: 5489047
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of betamethasone valerate inhalation on the hypothalamic-pituitary-adrenal axis or normal adults.
    Friedman M; Frears J; Crowley MF
    Postgrad Med J; 1974 Sep; 50 suppl 4():11-14. PubMed ID: 4467151
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function.
    Abraham G; Gottschalk J; Ungemach FR
    Endocrinology; 2005 Jul; 146(7):3163-71. PubMed ID: 15802495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term study of cloprednol in asthmatic patients.
    Miskovits G; Toth A; Parrott D
    Respiration; 1984; 45(2):147-53. PubMed ID: 6374803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the subacute effects of a new glucocorticoid, deflazacort, and prednisone on the hypothalamic-pituitary-adrenal axis of normal subjects.
    Wajchenberg BL; Cesar FP; Luthold WW; Okada H; Borghi VC
    Braz J Med Biol Res; 1986; 19(1):39-47. PubMed ID: 3542091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative changes in the function of muscle ribosomes and mitochondria during the early phase of steroid-induced catabolism.
    Bullock GR; Carter EE; Elliott P; Peters RF; Simpson P; White AM
    Biochem J; 1972 May; 127(5):881-92. PubMed ID: 5076236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recovery of hypothalamo-pituitary-adrenal function in the rat after prolonged treatment with betamethasone.
    Hodges JR; Mitchley S
    Br J Pharmacol; 1970 Dec; 40(4):732-9. PubMed ID: 4322042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of percutaneously absorbed steroids on hypothalamic--pituitary--adrenal function after intensive use in in-patients.
    Munro DD
    Br J Dermatol; 1976 Mar; 94 suppl 12():67-76. PubMed ID: 1268079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs.
    Banjanin S; Kapoor A; Matthews SG
    J Physiol; 2004 Jul; 558(Pt 1):305-18. PubMed ID: 15146051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine response to substitution of corticotrophin for oral prednisolone in asthmatic children.
    Malone DN; Drever JC; Grant IW; Percy-Robb IW
    Br Med J; 1972 Jul; 3(5820):202-5. PubMed ID: 4339254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function.
    Mikhail GR; Sweet LC; Mellinger RC
    Ann Allergy; 1973 Jul; 31(7):337-43. PubMed ID: 4352151
    [No Abstract]   [Full Text] [Related]  

  • 40. Topical corticosteroid therapy and pituitary-adrenal function.
    Krupin T; Mandell AI; Podos SM; Becker B
    Arch Ophthalmol; 1976 Jun; 94(6):919-20. PubMed ID: 938282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.